「Optimization of prediction methods for risk assessment of pathogenic germline variants in the Japanese population」の関連論文
-
A risk stratification model based on four novel biomarkers predicts prognosis for patients with renal cell carcinoma.
-
Genome-wide association study of serum prostate-specific antigen levels based on 1000 Genomes imputed data in Japanese : the Japan Multi-Institutional Collaborative Cohort Study
-
Comparison of efficacy and safety outcomes of anticancer drugs between Japanese patients and the overall population in multi-regional clinical trials
-
Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib
-
Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib
-
The impact of contour maps on estimating the risk of gastrointestinal stromal tumor recurrence: indications for adjuvant therapy: an analysis of the Kinki GIST registry
-
Risk factors for cisplatin-induced acute kidney injury: A pilot study on the usefulness of genetic variants for predicting nephrotoxicity in clinical practice
-
Utility of plasma circulating tumor DNA and tumor DNA profiles in head and neck squamous cell carcinoma
-
A large-scale targeted proteomics of plasma extracellular vesicles shows utility for prognosis prediction subtyping in colorectal cancer
-
Real-world application of next-generation sequencing-based test for surgically resectable colorectal cancer in clinical practice (本文)
-
Prognostic implications of preoperative versus postoperative circulating tumor DNA in surgically resected lung cancer patients: a pilot study
-
Endoscopy-focused primary, secondary and tertiary prevention of colorectal cancer
-
RT-PCR of peritoneal washings predicts peritoneal pancreatic cancer recurrence
-
A proof-of-concept study to construct Bayesian network decision models for supporting the categorization of sudden unexpected infant death
-
Breast magnetic resonance imaging for estimation of the tumour extent in patients with pure ductal carcinoma in situ: Comparison between full diagnostic and abbreviated protocols
-
A genome-wide association study identifying single nucleotide polymorphisms in the PPFIBP2 gene was predictive for interstitial lung disease in rheumatoid arthritis patients
-
Pharmacogenomic study of anti-tuberculosis drugs-induced liver injury in Thais
-
Mutation burden-orthogonal tumor genomic subtypes delineate responses to immune checkpoint therapy
-
Significance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinoma (本文)
-
Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer
-
Kinetic information from dynamic contrast-enhanced MRI enables prediction of residual cancer burden and prognosis in triple-negative breast cancer,a retrospective study
-
Genomic analysis for the prediction of prognosis in small-bowel cancer
-
Genomic analysis for the prediction of prognosis in small-bowel cancer
-
Modified Glasgow prognostic score is a pre-surgical prognostic marker of disease mortality in upper urinary tract urothelial carcinoma
-
Effect of body-mass index on the risk of gastric cancer among a Japanese population
-
Relationship between presarcopenia and event occurrence in patients with primary hepatocellular carcinoma
-
Clinical and Basic Research for Ovarian Cancer
-
Consumption of coffee and antioxidant vitamins and risk of lung cancer in Japan
-
Clinical impact of detecting low-frequency variants in cell-free DNA on treatment of castration-resistant prostate cancer
-
Immunohistochemically Detected Expression of ATRX, TSC2, and PTEN Predicts Clinical Outcomes in Patients With Grade 1 and 2 Pancreatic Neuroendocrine Tumors
-
Clinical characteristics and risk factors for mortality in patients with community-acquired staphylococcal pneumonia
-
Genomic analysis of multiple myeloma using targeted capture sequencing in the Japanese cohort
-
Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma
-
Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma
-
Prevalence of incidental meningiomas and gliomas on MRI : a meta-analysis and meta-regression analysis.
-
Evolutionary histories of breast cancer and related clones
-
Colorectal cancer-derived CAT1-positive extracellular vesicles alter nitric oxide metabolism in endothelial cells and promote angiogenesis
-
Differential effects of combination therapy on the components of the risk stratification table in patients with idiopathic or heritable pulmonary arterial hypertension in a Japanese population
-
Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testing (本文)
-
HLA-B*51:01 and CYP2C9*3 are risk factors for phenytoin-induced eruption in the Japanese population: analysis of data from the Biobank Japan Project
-
Albumin-Globulin Ratio Indicates the Survival Outcome of Pancreatic Cancer Cases Who Underwent Preoperative Treatment and Curative Surgical Resection
-
Lack of impact of the ALDH2 rs671 variant on breast cancer development in Japanese BRCA1/2‐mutation carriers
-
Risk factors and diagnostic biomarkers for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: Current evidence and future perspectives
-
Potential roles of gastroesophageal reflux in patients with superficial esophageal squamous cell carcinoma without major causative risk factors
-
The first-round results of a population-based cohort study of HPV testing in Japanese cervical cancer screening : baseline characteristics, screening results, and referral rate (本文)
-
若年成人就労女性における子宮頸がん検診受診の関連要因
-
A case of simultaneous breast cancer and ovarian cancer based on a hereditary breast and ovarian cancer syndrome
-
A novel urinary microRNA biomarker panel for detecting gastric cancer
-
The Identification of Risk Factors for Symptomatic Spinal Metastasis Onset: A Prospective Cohort Study of 128 Asymptomatic Spinal Metastasis Patients
-
Kynurenic acid is a potential overlapped biomarker between diagnosis and treatment response for depression from metabolome analysis